China medical devices exports to the GCC and India: size, growth and outlook 2026–2032

Chinese manufacturers are winning GCC tenders on price and India on volume — what buyers should check. Published estimates normalised to 2025 range from USD 50.5 bn to USD 52.7 bn; the Consulting Wallah central estimate is USD 50.5 bn, growing at about 5% a year to USD 71.1 bn by 2032. Scope differences between publishers explain most of the spread — the comparison table below states each one.

Growth is driven by china exports hit USD 50.47 bn in 2025 (+3.51%) with diagnostic & therapeutic equipment up 8.12% (Deep News); middle East exports growing 15.6-26% a year, UAE and Saudi Arabia the main growth drivers (CCCMHPIE; JoinChain); mindray overseas revenue >48% of total in 2025; United Imaging overseas revenue +65% with high-end CT/MR exports doubled (Deep News).

Context that matters for buyers and suppliers: China medical device exports reached USD 50.469 bn in 2025 (+3.51%); imports USD 34.835 bn (-2.72%). China exports to the Middle East were USD 1.94 bn in 2024, up 15.6%, with UAE and Saudi Arabia as growth drivers (CCCMHPIE). Saudi Arabia, UAE and Türkiye account for over 60% of China's medical device exports to the Middle East. India's medical device imports from China doubled from USD 622 mn (FY20) to USD 1.3 bn (FY24); China is India's second-largest source after the US.

The chart shows the Consulting Wallah central estimate: published figures normalised to 2025, median taken, and projected at the median published growth rate. The published range for 2025 is USD 50.5 bn–USD 52.7 bn; differences are mostly scope.

Included: capital equipment, implants, single-use consumables and IVD instruments and reagents. Excluded: pharmaceuticals, hospital IT, commodity PPE where reported separately. Publishers differ on whether IVD and consumables are included.

Shares as reported by the named sources; ranking is more reliable than the exact percentage.

• China medical device exports reached USD 50.469 bn in 2025 (+3.51%); imports USD 34.835 bn (-2.72%) (Deep News via Tiger Brokers)
• China exports to the Middle East were USD 1.94 bn in 2024, up 15.6%, with UAE and Saudi Arabia as growth drivers (CCCMHPIE) (Blooming)
• Saudi Arabia, UAE and Türkiye account for over 60% of China's medical device exports to the Middle East (JoinChain via Yicai Global)
• India's medical device imports from China doubled from USD 622 mn (FY20) to USD 1.3 bn (FY24); China is India's second-largest source after the US (Outlook India)
• Mindray's overseas revenue exceeded 48% of total in 2025; United Imaging's overseas revenue grew >65% (Deep News via Tiger Brokers)
• Disposable consumables exports from China were USD 10.52 bn in 2024, +13.91% (CCCMHPIE via Blooming)
• Most Chinese firms can only enter relatively small private hospitals in the Middle East, not public ones (SonoScape via Yicai Global)
• Before 2011 China's main medical device exports were low-end disposables such as syringes and gloves; Made in China 2025 (May 2015) named medical devices a priority sector (CFR)

Where the GCC and India sit

• Middle East (China exports, CCCMHPIE definition): USD 1.94 bn (+15.6%) (2024) — CCCMHPIE via Blooming
• Middle East (China exports, JoinChain definition): CNY 24.4 bn / USD 3.3 bn (+26%) (2024) — JoinChain via Yicai Global
• Saudi Arabia + UAE + Türkiye share of China's Middle East device exports: >60% (2024) — JoinChain via Yicai Global
• India imports of medical devices from China: USD 1.3 bn (FY2024) — Outlook India
• India imports of medical devices from China: USD 622 mn (FY2020) — Outlook India
• China total medical device exports: USD 50.469 bn (2025) — Deep News via Tiger Brokers

Consulting Wallah works this market from both sides: hospital groups in the UAE, Saudi Arabia, India and Bangladesh as buyers, and manufacturers in India, China, Singapore, Malaysia and the US as suppliers through the Network. Our observation is that registration status, in-country stock and structured quotations decide access in the GCC, while price and distributor reach decide it in India. CW observation

Opportunities we see: localised operations and overseas M&A to circumvent trade barriers (Deep News); high-tech diagnosis and treatment products are the fastest-growing export line to the Middle East (CCCMHPIE via Yicai); saudi Arabia, UAE and Türkiye already >60% of Middle East exports, concentrating go-to-market (JoinChain).

Key companies named across the sources; local distributors and implementation partners matter as much as the brand in the GCC and India.

• Manufacturers and exporters: registration first, local partner second, tender readiness third — see what GCC buyers need.
• Hospital leaders: total cost of ownership (service, consumables, software) outweighs purchase price; tender the bundle.
• Investors: local assembly and distribution platforms backed by procurement preference.

1. Deep News via Tiger Brokers, China medical device trade 2025 full-year analysis — itiger.com
2. Blooming (citing CCCMHPIE), Analysis and outlook on China's medical device import and export situation in 2024 — bloominglobal.com
3. Yicai Global, Chinese Medical Device Exports to Middle East Surge Though Brand Recognition Lags — yicaiglobal.com
4. Outlook India, Industry Flags Data Risks, Govt Plans Inquiry Into Chinese MedTech Imports — outlookindia.com
5. Council on Foreign Relations, Protected at Home, China's Medical Device Industry Looks Abroad — cfr.org
6. Tiger Brokers, China's Medical Device Import and Export Totaled $41.09 Billion in H1 2025 — itiger.com
7. Deep News (via Tiger Brokers), citing China customs/CCCMHPIE (2026-06) — USD 50.469 bn (China medical device exports, 2025, +3.51%); imports USD 34.835 bn (-2.72%); total trade USD 85.304 bn (2025) to — (), CAGR —; scope: country / China total medical device exports, full-year 2025 — source
8. China Chamber of Commerce for I&E of Medicines & Health Products (CCCMHPIE) via Blooming (2025) — USD 48.75 bn (China exports 2024, +7.3%); imports USD 35.8 bn (-4.7%); surplus USD 12.95 bn (2024) to — (), CAGR —; scope: country / China total medical device exports 2024; Middle East USD 1.94 bn (+15.6%) — source
9. Consulting Wallah Network — anonymised observations from procurement and business-setup work with hospital groups and suppliers in the UAE, India and Bangladesh (2024–26), used for the GCC/India outlook and the “what it means” section.
10. Method. Each published figure is normalised to a 2025 base using its own CAGR; the Consulting Wallah central estimate is the median of the normalised figures (or the stated scope where noted) projected at the median CAGR to 2032. Country figures are quoted as published; where we add a CW estimate it is labelled.